Cargando…

Repression of Alzheimer's beta-Secretase

Detalles Bibliográficos
Autores principales:	Liao, Francesca-Fang, Wang, Ruishan, Park, Edwards A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868720/ https://www.ncbi.nlm.nih.gov/pubmed/24177050

Ejemplares similares

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

γ-Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?
por: Toyn, Jeremy H., et al.
Publicado: (2013)

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
por: Nicsanu, Roland, et al.
Publicado: (2022)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

Beta secretase activity in peripheral nerve regeneration
por: Tallon, Carolyn, et al.
Publicado: (2017)

QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
por: Ponzoni, Ignacio, et al.
Publicado: (2019)

Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer's disease
por: Vakilian, Alireza, et al.
Publicado: (2019)

High Resolution Imaging Study of Interactions between the 37 kDa/67 kDa Laminin Receptor and APP, Beta-Secretase and Gamma-Secretase in Alzheimer's Disease
por: Jovanovic, Katarina, et al.
Publicado: (2014)

β-Secretases, Alzheimer's Disease, and Down Syndrome
por: Webb, Robin L., et al.
Publicado: (2012)

Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
por: Tate, Barbara, et al.
Publicado: (2012)

Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
por: Singh, Som, et al.
Publicado: (2022)

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
por: Volloch, Vladimir, et al.
Publicado: (2018)

The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase
por: Bolduc, David M, et al.
Publicado: (2016)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
por: Chávez-Gutiérrez, Lucía, et al.
Publicado: (2012)

Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022)

Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
por: Gil-Bea, Francisco, et al.
Publicado: (2012)

Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
por: Serneels, Lutgarde, et al.
Publicado: (2020)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics
por: Mouchlis, Varnavas D., et al.
Publicado: (2020)

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
por: Clementz, Anthony G, et al.
Publicado: (2009)

gamma-secretase activating protein is a therapeutic target for alzheimer ’s disease: a path-breaking discovery finally paving way towards therapeutic intervention
por: Ghosh, Aparajita, et al.
Publicado: (2011)

Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells
por: Zhu, Feiqi, et al.
Publicado: (2011)

Proteomics in neurons and animals: substrates and therapeutic potential of alpha-and beta-secretase
por: Lichtenthaler, Stefan
Publicado: (2013)

The beta secretase BACE1 regulates the expression of insulin receptor in the liver
por: Meakin, Paul J., et al.
Publicado: (2018)

Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration
por: Chacón-Quintero, María Victoria, et al.
Publicado: (2021)

Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
por: Wolfe, Michael S.
Publicado: (2021)

Beta-Secretase-1 Antisense RNA Is Associated with Vascular Ageing and Atherosclerotic Cardiovascular Disease
por: Bampatsias, Dimitrios, et al.
Publicado: (2022)

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
por: Doody, Rachelle S, et al.
Publicado: (2015)

Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
por: Basi, Guriqbal S, et al.
Publicado: (2010)

Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors
por: Arslanova, Dilyara, et al.
Publicado: (2010)

Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease
por: Kakuda, Nobuto, et al.
Publicado: (2012)

Gamma-secretase activating protein, a therapeutic target for Alzheimer's disease
por: He, Gen, et al.
Publicado: (2010)

Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease
por: Szaruga, Maria, et al.
Publicado: (2015)

The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease
por: MacLeod, Ruth, et al.
Publicado: (2015)

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment
por: Peron, Rafaela, et al.
Publicado: (2018)

Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
por: Acx, Hermien, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6qfgg9i2bb1c3qjj377co7liq